Evidence map›Paper›PMID 34712678›Full record

ArticleFrontiers in medicine2021

Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development.

Vadim Maratovich Gadelshin, Roberto Formento Cavaier, Ferid Haddad, Reinhard Heinke, Thierry Stora, Dominik Studer, Felix Weber, Klaus Wendt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 6 countries.

Vadim Maratovich GadelshinInstitut für Physik, Johannes Gutenberg-Universität, Mainz, Germany.
Roberto Formento CavaierAdvanced Accelerator Applications, A Novartis Company, Origgio, Italy.
Ferid HaddadGIP ARRONAX, Nantes, France.
Reinhard HeinkeInstitut für Physik, Johannes Gutenberg-Universität, Mainz, Germany.
Thierry StoraSY Department, CERN, Geneva, Switzerland.
Dominik StuderInstitut für Physik, Johannes Gutenberg-Universität, Mainz, Germany.
Felix WeberInstitut für Physik, Johannes Gutenberg-Universität, Mainz, Germany.
Klaus WendtInstitut für Physik, Johannes Gutenberg-Universität, Mainz, Germany.
Johannes Gutenberg University Mainz · DEEuropean Organization for Nuclear Research · CHInstitute of Physics and Technology · RUMontpellier GenomiX · FRNovartis (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terbium (Tb) is a promising element for the theranostic approach in nuclear medicine. The new CERN-MEDICIS facility aims for production of its medical radioisotopes to support related R&D projects in biomedicine. The use of laser resonance ionization is essential to provide radioisotopic yields of highest quantity and quality, specifically regarding purity. This paper presents the results of preparation and characterization of a suitable two-step laser resonance ionization process for Tb. By resonance excitation via an auto-ionizing level, the high ionization efficiency of 53% was achieved. To simulate realistic production conditions for Tb radioisotopes, the influence of a surplus of Gd atoms, which is a typical target material for Tb generation, was considered, showing the necessity of radiochemical purification procedures before mass separation. Nevertheless, a 10-fold enhancement of the Tb ion beam using laser resonance ionization was observed even with Gd:Tb atomic ratio of 100:1.

Indexed as

CERN-MEDICISgadoliniumisotope separationlaser resonance ionizationRISIKO mass separatorterbiumtheranosticsTi:Sapphire laser

Identifiers

PMID34712678
PMCPMC8546115
OpenAlexW3207442316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.